IL12A and liver cancer: showed that AR could suppress IL-12A expression at the transcriptional level via direct binding to the IL-12A promoter region which results in repressing the efficacy of natural killer (NK; related innate immune surveillance) cell cytotoxicity against liver cancer cells.